Tokyo: Life Sciences and Health Care Horizons 2019
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
Cross-border M&A: focus on antitrust filings
12 September 2019
Exciting Trends in Japanese Tech M&A
14 March 2019
In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...
Going Global 2018
Tokyo: 28 Nov 2018, Osaka: 26 Nov 2018
Cross-practice, multi-track seminar on advanced trademark issues, global M&A transactions, global patent updates for technology companies, energy investments, and recent...
Going Global 2017
Tokyo: 16 November 2017 at 09:30 - 18:00 ; Osaka: 13 November 2017 9:30 - 18:00
We are hosting a cross-practice, multi-track seminar on November 16 (Tokyo) and November 13 (Osaka). Join us to find out about a new approach to brand management, the latest developments in ...
Japan In-House Lawyers Association Seminar: A Global Perspective on avoiding Bribery and Corruption Pitfalls
12 May 2017
One of the key risks that Japanese companies face as they expand their businesses overseas is cartel, corruption and bribery risks. Companies need to be aware of these risks especially when ...
The Global Antitrust Corner – Circumnavigating the Merger Control World
01 October 2015 | 3:00 PM - 4:00 PM (DST)
Global M&A activity has continued at a steady pace in 2015, with an increasing number of transactions raising antitrust issues under multiple merger control regimes. Beyond the U.S. and ...
